Specific immunotherapy – an optimistic future
Open Access
- 31 August 2006
- Vol. 61 (10) , 1155-1158
- https://doi.org/10.1111/j.1398-9995.2006.01237.x
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- The future of immunotherapy. Report of a National Institute of Allergy and Infectious Diseases (NIAID), Division of Allergy, Immunology and Transplantation (DAIT) WorkshopAllergy, 2006
- Safety and tolerability of grass pollen tablets in sublingual immunotherapy – a phase‐1 studyAllergy, 2006
- Safety of a SQ‐standardised grass allergen tablet for sublingual immunotherapy: a randomized, placebo‐controlled trialAllergy, 2006
- Allergen-specific sublingual immunotherapy: less mystic, more scientificAllergy, 2006
- Pharmacokinetics of Der p 2 Allergen and Derived Monomeric Allergoid in Allergic VolunteersInternational Archives of Allergy and Immunology, 2005
- Allergen-specific immunotherapy with recombinant grass pollen allergensJournal of Allergy and Clinical Immunology, 2005
- Canadian trial of sublingual swallow immunotherapy for ragweed rhinoconjunctivitisAnnals of Allergy, Asthma & Immunology, 2004
- Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria‐induced respiratory allergy: a randomized controlled trial†Allergy, 2004
- Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double‐blind placebo‐controlled studyAllergy, 2004
- Effectiveness of specific immunotherapy in the treatment of allergic rhinitis: An analysis of randomized, prospective, single- or double-blind, placebo-controlled studiesClinical Therapeutics, 2000